Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.

by Luca Massacesi, Irene Tramacere, Salvatore Amoroso, Mario A Battaglia, Maria Donata Benedetti, Graziella Filippini, Loredana La Mantia, Anna Repice, Alessandra Solari, Gioacchino Tedeschi, Clara Milanese
Published 2014-01-01

Motor Imagery as a Function of Disease Severity in Multiple Sclerosis: An fMRI Study

by Andrea Tacchino, Catarina Saiote, Catarina Saiote, Giampaolo Brichetto, Giulia Bommarito, Luca Roccatagliata, Luca Roccatagliata, Christian Cordano, Mario A. Battaglia, Gian L. Mancardi, Matilde Inglese, Matilde Inglese, Matilde Inglese, Matilde Inglese
Published 2018-01-01

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of m...

by Antonio Uccelli, Alice Laroni, Lou Brundin, Michel Clanet, Oscar Fernandez, Seyed Massood Nabavi, Paolo A. Muraro, Roberto S. Oliveri, Ernst W. Radue, Johann Sellner, Per Soelberg Sorensen, Maria Pia Sormani, Jens Thomas Wuerfel, Mario A. Battaglia, Mark S. Freedman, on behalf of the MESEMS study group
Published 2019-05-01